The FDA’s Commissioner’s National Priority Voucher (CNPV) Pilot Program, launched in June 2025, creates a highly accelerated 1–2 month review pathway for products addressing key national health priorities such as unmet medical needs, domestic manufacturing resiliency, public health threats, healthcare affordability, and advanced therapeutic innovation. Entry into the program may occur through FDA nomination or a brief sponsor- submitted application.
White Paper
Commissioner’s National Priority Voucher (CNPV) Pilot Program
Related Resources
All Resources
infographic
Understanding the Stakes of IND Submissions: Why Timely Approvals Matter
Read More
post
291 FDA Complete Response Letters Decoded: Insights for Biologics CMC Strategy
Read More
post
Oral Drug Product Development of Small Molecules
Read More
webinar
Ask Me Anything Series – CMC and Regulatory Alignment: Lessons from the Front Lines
Read More
Let's move from science to success.
Let’s Talk